Your session is about to expire
← Back to Search
Antiretroviral Therapy Regimen for HIV
Study Summary
This trial is testing whether the addition of GW433908 to the existing drug regimen of ABC/3TC can improve viral response in patients who have not yet taken ART drugs.
Timeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I may qualify for this study.You have previously participated in studies testing new treatments or medications.I have a serious health condition like diabetes or heart disease.I haven't had chemotherapy or radiation in the last 28 days and won't need them during the study.I haven't taken immune-affecting or anti-HIV drugs in the last 28 days.I do not abuse drugs or alcohol in a way that would affect my participation in the study, or I am stable on methadone.I have had pancreatitis or hepatitis in the last 6 months.I have received an HIV vaccine in the last 3 months.I haven't taken certain drugs in the last 28 days and don't expect to need them during the study.I've taken NRTI for less than 4 weeks and never taken NNRTI or PI, except possibly one dose of nevirapine during pregnancy.I cannot take medicines by mouth.I am at least 13 years old and have consent if under 18.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are subjects still being accepted for participation in this trial?
"No, this particular trial is not currently looking for patients. Although, it is worth mentioning that there are 495 other clinical trials that are still recruiting patients."
Does this treatment present any risks for patients?
"This clinical trial is in Phase 3, which indicates that while there is some efficacy data, more rounds of testing are needed to confirm safety. Therefore, the Power team gave this treatment a score of 3."
Does this research include middle-aged or elderly individuals?
"This trial is only for patients aged 13+, which differentiates it from 109 other studies for minors and 364 studies for older adults."
Can I join this clinical trial?
"This trial is looking for 624 hiv positive participants aged 13 and up. To meet the criteria for this study, potential patients must: Be above the age of 13 ( parental/guardian consent needed if under 18), Use a reliable form of birth control during the study period (hormonal birth control will not be accepted), if able to have children., Have received less than 4 weeks treatment with any nucleoside reverse transcriptase inhibitor (NRTI) and have never received any nonnucleoside reverse transcriptase inhibitor (NNRTI) or protease inhibitor (PI). Mothers who have previously received 1 dose of the"
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger